ML 315 hydrochloride
Inhibitor of cdc2-like kinases (Clk) and DYRK kinases (IC50 values are 68, 68 and 231 nM for Clk1, Clk4 and Clk2, respectively, and 282 and 1156 nM for Dyrk1A and Dyrk1B). Shows 20-fold selectivity for Clk4 over Dyrk1A. Stable in both mouse and human plasma. Moderately cell permeable.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 410.68. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||2.43 mL||12.17 mL||24.35 mL|
|5 mM||0.49 mL||2.43 mL||4.87 mL|
|10 mM||0.24 mL||1.22 mL||2.43 mL|
|50 mM||0.05 mL||0.24 mL||0.49 mL|
References are publications that support the products' biological activity.
Coombs et al (2013) Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315. Bioorg.Med.Chem.Lett. 23 3654 PMID: 23642479
If you know of a relevant reference for ML 315 hydrochloride, please let us know.
View Related Products by Product Action
Keywords: ML 315 hydrochloride, supplier, ML315, HCl, Inhibitors, Inhibits, Cdc2-like, kinases, Clk, kinase, Dual, specificity, tyrosine, phosphorylation-regulated, kinases, DYRK, kinase, Cdc2-like, kinases, DYRK, Cdc2-like, kinases, Tocris Bioscience
Citations for ML 315 hydrochloride
Citations are publications that use Tocris products.
Currently there are no citations for ML 315 hydrochloride. Do you know of a great paper that uses ML 315 hydrochloride from Tocris? If so please let us know.
ML 315 hydrochloride Reviews
Average Rating:(Based on 0 Reviews)